BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22876303)

  • 1. Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice.
    Takaoka Y; Shimizu Y; Hasegawa H; Ouchi Y; Qiao S; Nagahara M; Ichihara M; Lee JD; Adachi K; Hamaguchi M; Iwamoto T
    PLoS One; 2012; 7(8):e42137. PubMed ID: 22876303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of RNA helicases p68 and p72 in colon cancer.
    Shin S; Rossow KL; Grande JP; Janknecht R
    Cancer Res; 2007 Aug; 67(16):7572-8. PubMed ID: 17699760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
    Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
    Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
    [No Abstract]   [Full Text] [Related]  

  • 4. RNA helicase p68 deploys β-catenin in regulating RelA/p65 gene expression: implications in colon cancer.
    Khare V; Tabassum S; Chatterjee U; Chatterjee S; Ghosh MK
    J Exp Clin Cancer Res; 2019 Jul; 38(1):330. PubMed ID: 31351496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-talented DEAD-box proteins and potential tumor promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17).
    Janknecht R
    Am J Transl Res; 2010 May; 2(3):223-34. PubMed ID: 20589163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase.
    Mooney SM; Goel A; D'Assoro AB; Salisbury JL; Janknecht R
    J Biol Chem; 2010 Oct; 285(40):30443-52. PubMed ID: 20663877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential.
    Mooney SM; Grande JP; Salisbury JL; Janknecht R
    Biochemistry; 2010 Jan; 49(1):1-10. PubMed ID: 19995069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sunitinib malate inhibits intestinal tumor development in male Apc
    Chen L; Xu P; Xiao Q; Chen L; Li S; Jian JM; Zhong YB
    Int Immunopharmacol; 2021 Jan; 90():107128. PubMed ID: 33191180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for the tissue specificity of β-catenin oncogenesis.
    Sharma A; Sen JM
    Oncogene; 2013 Apr; 32(15):1901-9. PubMed ID: 22689057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel pathway partners of p68 and p72 RNA helicases through Oncomine meta-analysis.
    Wilson BJ; Giguère V
    BMC Genomics; 2007 Nov; 8():419. PubMed ID: 18005418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.
    Li QQ; Xie YK; Wu Y; Li LL; Liu Y; Miao XB; Liu QZ; Yao KT; Xiao GH
    Oncotarget; 2017 Feb; 8(7):12067-12080. PubMed ID: 28076844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs.
    Fukuda T; Yamagata K; Fujiyama S; Matsumoto T; Koshida I; Yoshimura K; Mihara M; Naitou M; Endoh H; Nakamura T; Akimoto C; Yamamoto Y; Katagiri T; Foulds C; Takezawa S; Kitagawa H; Takeyama K; O'Malley BW; Kato S
    Nat Cell Biol; 2007 May; 9(5):604-11. PubMed ID: 17435748
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Jiang L; Hermeking H
    Cancer Res; 2017 May; 77(10):2746-2758. PubMed ID: 28363996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DEAD-box p68/p72 proteins and the noncoding RNA steroid receptor activator SRA: eclectic regulators of disparate biological functions.
    Caretti G; Lei EP; Sartorelli V
    Cell Cycle; 2007 May; 6(10):1172-6. PubMed ID: 17495528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex.
    Garibaldi F; Falcone E; Trisciuoglio D; Colombo T; Lisek K; Walerych D; Del Sal G; Paci P; Bossi G; Piaggio G; Gurtner A
    Oncogene; 2016 Jul; 35(29):3760-70. PubMed ID: 26996669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.
    Jiang FZ; He YY; Wang HH; Zhang HL; Zhang J; Yan XF; Wang XJ; Che Q; Ke JQ; Chen Z; Tong H; Zhang YL; Wang FY; Li YR; Wan XP
    Oncotarget; 2015 Dec; 6(42):44660-74. PubMed ID: 26587974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of p72 Enhances Malignant Migration and Invasion of Glioma Cells by Repressing Beclin1 Expression.
    Zhang Z; Tian H; Miao Y; Feng X; Li Y; Wang H; Song X
    Biochemistry (Mosc); 2016 Jun; 81(6):574-82. PubMed ID: 27301285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
    Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA
    Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.
    Sarkar M; Khare V; Guturi KK; Das N; Ghosh MK
    Oncogene; 2015 Nov; 34(47):5843-56. PubMed ID: 25745998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.